Peptides DB
Research-centric peptide and protocol reference hub
Study 15 of 15ARA 290 literatureJAMATop journal2026

Amyloid PET Quantitation and Centiloid Thresholds in the Diagnosis of Alzheimer Disease: An Individual Participant Data Meta-Analysis.

Not reported in abstract.

Read at JAMAAdd to compare

Where it sits

this study against the rest of the ara 290 corpus
4
Preclinical · this one
9
Observational
0
Open-label
0
Randomised
2
Reviews

Summary and findings

Not reported in abstract.

How much of this paper we could read: title only (0.10). The feed gave us little more than the title, so our summary is thin. This says nothing about the study's quality — read the source. What this means →
2026

Abstract

The authors’ words, as JAMA supplied them

<h4>Importance</h4>Amyloid positron emission tomography (PET) is increasingly used in research and clinical settings to determine the etiology of cognitive decline and eligibility for amyloid-targeting therapies. To assist with amyloid PET evaluation and to guide clinical decision-making, images can be quantified in a standardized unit called Centiloid, the interpretation of which can vary according to the method and threshold used.<h4>Objective</h4>To collect Centiloid values from available studies and determine robust positivity cutoffs using data-driven methods and correspondence with visual reads.<h4>Data sources</h4>PubMed search (October 2024) identified studies with Centiloid values. Corresponding authors were invited to share individual participant data. Additional data were obtained through access-controlled repositories and conference outreach (July 2024-July 2025).<h4>Study selection</h4>Studies were included if they provided Centiloids, radiotracer, age, and sex.<h4>Data extraction and synthesis</h4>Each study was analyzed using a unified statistical pipeline; study estimates were pooled using random-effects meta-analysis.<h4>Main outcomes and measures</h4>Gaussian mixture models (GMMs) were fitted to Centiloid values for each study. In studies with a bimodal distribution (per integrated completed likelihood), single cutoffs for positivity were set as mean plus 2 SDs of the lower gaussian component. Using GMMs, a double-cutoff approach defined a lower certainty range using a 90% posterior probability cutoff for assignment to the low (amyloid-negative) vs high (amyloid-positive) component. An alternative Centiloid cutoff was derived from maximizing the correspondence (Cohen κ) with the binary visual reads when available.<h4>Results</h4>This meta-analysis included cross-sectional amyloid PET scans acquired with 5 radiotracers from 49 227 participants across 53 studies from 15 countries (mean age, 71 years; 54% female, 62% cognitively impaired). The data-driven GMM approach identified a bimodal distribution in 51 studies (n = 48 786), resulting in a single cutoff for positivity of 18 Centiloids (95% CI,16-19; I2 = 97%). The double-cutoff approach revealed high confidence for interpreting scans as negative when Centiloid values were lower than 11 (95% CI, 9-13; I2 = 95%) and interpreting scans as positive if Centiloid values were higher than 26 (95% CI, 24-28; I2 = 95%). In analyses of correspondence with binary (positive or negative) visual reads of amyloid PET scans (n = 35 045; 36 studies), Centiloids were highly predictive of visual positivity (Cohen κ, 0.86; 95% CI, 0.83-0.89; I2 = 96%) with a cutoff of 27 Centiloids (95% CI, 24-30; I2 = 80%).<h4>Conclusions and relevance</h4>In this individual participant data meta-analysis, positivity cutoffs converged around 18 Centiloids (data-driven) and 27 Centiloids (visual reads). Findings from a double-cutoff analysis suggest that scans in the 11 to 26 Centiloid range should be interpreted with caution depending on the context of use.

Background

Not reported in abstract.

Methods

Not reported in abstract.

Results

Not reported in abstract.

Interpretation

Not reported in abstract.

Limitations

Not reported in abstract.

Elsewhere in the ARA 290 corpus

DTemocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.Lancet (London, England) · 2026CImmunometabolic dysregulation drives selective executive cognitive dysfunction in male db/db mice.Neurobiology of disease · 2026 · Not reported in abstract.AnimalBAssociation of Fish Consumption with the Omega-3 Index and Vitamin D Status among Adolescent Females in the Southwest Coastal Zone of Bangladesh.The Journal of nutrition · 2026 · Mean O3I was 4.3% during dry season and 4.9% in wet season.HumanBCaffeine Consumption Pattern and Associated Side Effects and Withdrawal Syndromes Among University Students of Bangladesh.Health science reports · 2026 · 34.0% drinking caffeine once daily, n=not reported in abstract.HumanBMetabolic pathways and chemotherapy resistance in acute myeloid leukemia (AML): Insights into Enoyl-CoA hydratase domain-containing protein 3 (&lt;i&gt;ECHDC3&lt;/i&gt;) as a potential therapeutic target.Cancer pathogenesis and therapy · 2026 · Knockdown of ECHDC3 significantly reduced the mitochondrial membrane potential, p < 0.0001.HumanBAntenatal depressive symptoms impair offspring neurodevelopment by inducing maternal gut microbiota dysbiosis during pregnancy.Gut microbes · 2026 · Not reported in abstract.Human